Regenerative Medicine Companies Explore Diverse Approaches
Promising modalities include engineered patches, gelatinous fillers, colloidal matrices, organoid implants, and cancer stem cell–primed immunotherapies.
Stay updated with breaking news from Avery Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Promising modalities include engineered patches, gelatinous fillers, colloidal matrices, organoid implants, and cancer stem cell–primed immunotherapies.
Share this article Share this article I Peace's GMP-grade iPSCs are key to manufacture Avery Therapeutics' MyCardia™, a proprietary tissue-engineered heart graft developed to treat heart failure TUCSON, Ariz. and PALO ALTO, Calif., Dec. 16, 2020 /PRNewswire/ -- Avery Therapeutics, a Tucson-based company dedicated to advancing tissue-engineered therapeutics to treat diseases and injuries to human muscle, and I Peace, Inc., a Palo Alto-based biotech startup developing, mass-manufacturing, and commercializing Nobel Prize-wining technology of induced pluripotent stem cells (iPSCs), announced a ...